Dr. Brandon Patrick Goodwin, MD

Dr. Goodwin practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Goodwin's NPI, 1730478611, was assigned on March 31, 2011. Dr. Goodwin graduated from Frederick P. Whiddon College of Medicine in 2011. Dr. Goodwin's Texas license number on file is Q0447.

Dr. Goodwin's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Goodwin's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. Dr. Goodwin is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Goodwin to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodwin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Goodwin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Goodwin is board certified in dermatology by the American Board of Dermatology. Dr. Goodwin has a license on file in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Goodwin treats.

CMS data shows 2,859 Medicare services from Dr. Goodwin across 15 procedure codes in 2024, for 768 Medicare patients. Medicare paid $75,179 for them.

CMS counts 768 Medicare patients who saw Dr. Goodwin in 2024. The largest group is 65 to 74, with 414 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goodwin's median patient age at 72, with 48% women.

In 2024, Dr. Goodwin wrote 239 Medicare Part D claims for 98 patients. 85% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $47,057 in total drug cost. In 2023, CMS named 162 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Goodwin for performance year 2024, reported as part of a group. Dr. Goodwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 644 procedures of removal of skin lesions by Dr. Goodwin, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Goodwin, published from 2023 to 2024. Dr. Goodwin's most frequent co-authors are Caroline Elizabeth Hagan, MD, Kathleen Tran Kroger, MD and Xavier Alexander Rice, MD.

CMS Open Payments shows 14 general payments to Dr. Goodwin from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $700.

Dr. Goodwin graduated from Frederick P. Whiddon College of Medicine in 2011.

Dr. Goodwin is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.